SAB Biotherapeutics Correlations
| SABSW Stock | USD 0.05 0.02 28.53% |
The current 90-days correlation between SAB Biotherapeutics and Lyra Therapeutics is -0.09 (i.e., Good diversification). The correlation of SAB Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
SAB Biotherapeutics Correlation With Market
Significant diversification
The correlation between SAB Biotherapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
SAB |
Moving together with SAB Stock
| 0.67 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.64 | VRNA | Verona Pharma PLC | PairCorr |
| 0.62 | VSTM | Verastem | PairCorr |
Moving against SAB Stock
| 0.64 | DTIL | Precision BioSciences | PairCorr |
| 0.56 | ME | 23Andme Holding | PairCorr |
| 0.36 | VCNX | Vaccinex | PairCorr |
| 0.32 | DRMA | Dermata Therapeutics | PairCorr |
| 0.31 | VALN | Valneva SE ADR | PairCorr |
| 0.7 | EDSA | Edesa Biotech Fiscal Year End 20th of December 2024 | PairCorr |
| 0.63 | VINC | Vincerx Pharma | PairCorr |
| 0.6 | VXRT | Vaxart Inc | PairCorr |
| 0.45 | EDIT | Editas Medicine | PairCorr |
| 0.43 | VRAX | Virax Biolabs Group | PairCorr |
| 0.4 | DYAI | Dyadic International | PairCorr |
| 0.33 | VTVT | vTv Therapeutics | PairCorr |
Related Correlations Analysis
| -0.5 | 0.02 | 0.62 | -0.1 | -0.15 | CGEM | ||
| -0.5 | 0.08 | -0.37 | -0.06 | 0.5 | AVTE | ||
| 0.02 | 0.08 | -0.14 | 0.64 | 0.28 | GPCR | ||
| 0.62 | -0.37 | -0.14 | -0.51 | -0.5 | LYRA | ||
| -0.1 | -0.06 | 0.64 | -0.51 | 0.35 | GOSS | ||
| -0.15 | 0.5 | 0.28 | -0.5 | 0.35 | INBX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between SAB Stock performing well and SAB Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SAB Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CGEM | 2.63 | (0.30) | (0.04) | 0.01 | 3.72 | 6.13 | 14.90 | |||
| AVTE | 2.57 | 0.53 | 0.21 | 0.61 | 2.14 | 5.58 | 19.11 | |||
| GPCR | 2.68 | 0.10 | 0.02 | 0.29 | 2.71 | 8.03 | 21.24 | |||
| LYRA | 3.16 | (0.20) | 0.00 | (0.01) | 0.00 | 7.69 | 23.21 | |||
| GOSS | 2.52 | 0.04 | (0.01) | 0.22 | 2.25 | 6.06 | 16.84 | |||
| INBX | 2.13 | 0.49 | 0.21 | 0.75 | 1.83 | 6.22 | 16.75 |
SAB Biotherapeutics Corporate Executives
Elected by the shareholders, the SAB Biotherapeutics' board of directors comprises two types of representatives: SAB Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SAB. The board's role is to monitor SAB Biotherapeutics' management team and ensure that shareholders' interests are well served. SAB Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SAB Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward DVM | CoFounder Observer | Profile | |
| Michael King | EVP CFO | Profile | |
| Christoph MBA | Executive COO | Profile |